The year 2023 started with disappointing news for the field of human immunodeficiency virus (HIV) research after Janssen’s Phase III vaccine trial failed. Read More
Reading Time: < 1 minuteFunding for HIV responses in low- and middle-income countries fell by $2.1 billion (£1.6bn) last year after the Trump administration made substantial…